BackgroundWhole grain (WG) intake is associated with reduced risk of obesity, type 2 diabetes and cardiovascular disease, whereas type 2 diabetes increases the risk of cognitive decline and dementia. The purpose of this study was to investigate the effects of short-term intervention with WG rye on cognitive functions, mood and cardiometabolic risk markers in middle-aged test subjects.MethodRye-based breads were provided to 38 healthy test subjects (aged 52-70y) during three consecutive days in a crossover study design, using white wheat flour bread (WWB) as a reference. The rye-based bread consisted of a WG rye kernel/flour mixture (1:1 ratio) supplemented with resistant starch type 2 (RS2) (RB?+?RS2). The last bread portion was ingested at 2100 h, and cognitive function, mood and cardiometabolic risk markers were determined the following morning, 11???14 h post intake.ResultsIn comparison to WWB, the RB?+?RS2 product increased ratings of mood parameters (valance, P?<?0.001; activation P?<?0.05). No differences were seen in the cognitive tests depending on intervention (P?>?0.05). RB?+?RS2 increased insulin sensitivity (P?<?0.05), fasting levels of gut hormones (PYY, P?<?0.05; GLP-2, P?<?0.01) and fasting concentrations of plasma acetate, butyrate and total SCFA (P?<?0.001). In contrast, fasting levels of IL???1β were decreased (P?<?0.05). Insulin sensitivity was positively correlated with working memory test performance (P?<?0.05).ConclusionsThis study display novel findings regarding effects of WG rye products on mood, and glucose and appetite regulation in middle-aged subjects, indicating anti-diabetic properties of WG rye. The beneficial effects are suggested to be mediated through gut fermentation of dietary fiber in the RB?+?RS2 product.Trial registrationThe study was retrospectively registered at ClinicalTrials.gov, register number NCT03275948. Registered September 8 2017. |
